The maintenance of an Outperform rating and a high price target by a reputable analyst like Hartaj Singh from Oppenheimer suggests a strong confidence in Gilead Sciences' future performance. This endorsement is likely to instill positive sentiment among investors, potentially driving up the stock price in the short term.